Cleared Traditional

K971991 - GESCO PER-Q-CATH MIDLINE CATHETERS

K971991 is an FDA 510(k) clearance for GESCO PER-Q-CATH MIDLINE CATHETERS, manufactured by Bard Access Systems, Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 182-day FDA review.

K971991 · Bard Access Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
182d
Days
Class 2
Risk

K971991 is an FDA 510(k) clearance for the GESCO PER-Q-CATH MIDLINE CATHETERS. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Bard Access Systems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on November 7, 1997 after a review of 182 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Bard Access Systems, Inc. devices

FDA 510(k) Submission Details - K971991

510(k) Number K971991 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 1997
Decision Date November 07, 1997
Days to Decision 182 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 129d · This submission: 182d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 399
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K971991.
L-CATH MODIFIED SELDINGER TECHNIQUE INSERTION/CATHETER EXCHANGE KIT PE-MST24-24 GA. KIT, L-CATH MODIFIED SELDINGER
K974543 · Luther Medical Products, Inc. · Feb 1998
INSYTE, INSYTE-W, INSYTE AUTOGUARD CATHETERS
K971339 · Becton Dickinson Vascular Access, Inc. · Dec 1997
GESCO PER-Q-CATH PICC CATHETERS
K971990 · Bard Access Systems, Inc. · Nov 1997
ARROW-HOWES LARGE BORE MULTI-LUMEN CENTRAL VENOUS CATHETERS
K970864 · Arrow Intl., Inc. · Oct 1997
FIRST PICC CATHETER
K972262 · Becton Dickinson Infusion Therapy Systems, Inc. · Sep 1997
FIRST PICC CATHETER WITH DUAL LUMENS
K972263 · Becton Dickinson Infusion Therapy Systems, Inc. · Sep 1997